SIGNIFICANTLY IMPROVED ABDOMINAL PAIN (AP) WITH LINACLOTIDE (LIN) VS PLACEBO (PBO) IN PATIENTS (PTS) WITH IRRITABLE BOWEL SYNDROME (IBS) REGARDLESS OF BASELINE PAIN SEVERITY IN 2 PHASE 3 TRIALS

(1) Ironwood Pharmaceuticals

(2) Univ of Michigan

(3) Forest Research Institute



This item was part of the OTHER LOWER GI DISORDERS III session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A421